The Role of Obesity in Cancer Survival and Recurrence Workshop Summary (2012) / Chapter Skim
Currently Skimming:
Appendix C: Speaker Biographies
Appendix C: Speaker Biographies
Pages 91-110
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 91... ...
Her own research focuses in the areas of physical activity, diet, and weight at the individual, population, and policy level, and quality of cancer care in the area of screening and treatment. She has also focused on improving methods and systems for tracking cancer preventive measures in national and local populations, and on examining the delivery of health care utilization and services in screening and treatment.
|
From page 92... ...
She leads an NCI effort to advance research on the combined effects of diet, physical activity, and weight on cancer, serves on the Senior Leadership Group for the National Institutes of Health (NIH) Obesity Research Task Force, and advances NIH's research in the NIH/Centers for Disease Control and Prevention/Robert Wood Johnson Foundation National Collaborative on Childhood Obesity Research to advance research that identifies population-level solutions to the childhood obesity epidemic.
|
From page 93... ...
He serves as principal investigator of a multicenter, international consortium, the Great Lakes/New England Clinical Epidemiology and Validation Center of the Early Detection Research Network. This National Cancer Institute–funded cooperative network focuses on the discovery and validation of new surrogate endpoint biomarkers for early diagnosis of carcinogenesis in humans.
|
From page 94... ...
Landon-American Association for Cancer Research Prize for Translational Cancer Research in 2006, which recognizes "seminal contributions to our understanding of cancer through basic and translational research." Aromatase inhibitors help to prevent recurrence of breast cancer in postmenopausal women by reducing the level of estrogen in the body, thereby cutting off the fuel that promotes the growth of cancer cells.
|
From page 95... ...
He is also team co-leader for the Alberta Moving Beyond Breast Cancer Cohort Study designed to determine the associations between physical activity, healthrelated fitness, and disease outcomes in newly diagnosed Alberta breast cancer survivors. He has co-authored the American Cancer Society's physical activity and nutrition guidelines and the American College of Sports Medicine's exercise guidelines for cancer survivors.
|
From page 96... ...
Demark-Wahnefried also serves on several committees, including the American Cancer Society's Guidelines Panel for Nutrition and Physical Activity among Cancer Survivors, the World Cancer Research Fund, and the American College of Sports Medicine Guidelines Panel for Physical Activity in Cancer Survivors, and the American Society of Clinical Oncology Committee on Cancer Survivorship. John DiGiovanni, PhD, is professor of pharmacology and toxicology at the University of Texas at Austin.
|
From page 97... ...
The overall goal of this research is to identify molecular targets and strategies to offset the increased cancer risk and mortality associated with obesity. Cancers currently under study in the laboratory include both melanoma and non-melanoma skin cancers, prostate cancer, head and neck squamous cell carcinoma, and lymphoma.
|
From page 98... ...
She has been a member of the faculty of the UCLA School of Medicine since 1978 and the UCLA School of Public Health since 1992. Since 1993 she has been the director of the Division of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center.
|
From page 99... ...
At the Jonsson Comprehensive Cancer Center, she directs the Division of Cancer Prevention and Control Research, and leads the scientific program focused on patients and survivors. In 1997 she established the UCLA Family Cancer Registry and Genetic Evaluation Program, which serves patients and survivors, as well as those at high risk for familial/hereditary cancers.
|
From page 100... ...
Dr. Gapstur has served on several national and international committees including the National Institutes of Health, Center for Scientific Review, Epidemiology of Cancer peer review committee, the National Cancer Institute Subcommittee A (Cancer Center Support Grants)
|
From page 101... ...
Her research focuses on translational investigation of nutritional and pharmaceutical interventions for cancer risk reduction. Her lab is investigating stem cells and signaling pathways regulating their self renewal and differentiation such as Wnt, Notch, and Hedgehog as targets for cancer risk reductive interventions or biomarkers for cancer risk reduction intervention efficacy assessment in early phase human clinical trials.
|
From page 102... ...
Jennifer A Ligibel, MD, is assistant professor in the department of medicine at Harvard Medical School, and attending physician, adult oncology, at Dana-Farber Cancer Institute (DFCI)
|
From page 103... ...
She is principal investigator of the Seattle site of Health, Eating, Activity, and Lifestyle Study, which is assessing associations of anthropometrics, fat mass, sex and metabolic hormones, inflammation, vitamin D, diet, and physical activity with prognosis in breast cancer survivors. She is also principal investigator of the Seattle site of the ExCel trial which tested the effect of exemestane, an aromatase inhibitor, on breast cancer prevention, and she led an RCT testing aspirin effect on breast cancer biomarkers.
|
From page 104... ...
Through this network, community oncologists participate in cancer clinical trials in treatment, prevention, and cancer control. The network sponsors the large breast and prostate cancer prevention trials, several smaller prevention trials in disease sites that include colon, head and neck cancer, lung cancer, and bladder cancer, as well as numerous symptom management and other cancer control clinical trials.
|
From page 105... ...
He was the charter chairman of the Scientific Advisory Board of ALMAC Diagnostics (2000 to 2008) , a founding member of Queen's University School of Medicine International Review Board, chairman of The Conquer Cancer Foundation of the American Society of Clinical Oncology, a founding director of the All-Ireland Cancer Foundation, and a director of the American Cancer Society Foundation (2000 to 2009)
|
From page 106... ...
She was awarded a post-doctoral appointment at the NCI's Cancer Prevention Research Branch, in the NCI Cancer Prevention Fellowship Program.
|
From page 107... ...
Partridge is principal investigator for the Deep South Network for Cancer Control, a community-based participatory research network, as well as a partnership involving the UAB Comprehensive Cancer Center, Morehouse School of Medicine and Tuskegee University. The federally supported network pairs research at UAB with investigators at historically black colleges and universities, to enhance cancer disparity research.
|
From page 108... ...
and the American Cancer Society that are testing whether modifications in diet and level of physical activity can alter
|
From page 109... ...
Dr. Wadden's principal research is on the treatment of obesity by methods that have included lifestyle modification, physical activity, verylow-calorie diets, medication, and surgery.
|
From page 110... ...
She completed her internal medicine residency at University of Washington and her medical oncology fellowship at the University of Washington and Fred Hutchinson Cancer Research Center.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.